The Argument in Favor of Flu Vaccination
DOI:
https://doi.org/10.17140/VROJ-3-e006Keywords:
Organization, Prevention, vaccinationAbstract
I
nfluenza or flu vaccine encompasses the seasonal vaccination
that protects against infection by the influenza viruses.1
It’s
generally available in two forms; the inactive form administered as
shots or intramuscular injections and the weakened live viral forms
sprayed intranasally.
The flu vaccination is generally safe and listed among
the WHO list of Essential Medicines.2
It is currently the best
way to protect the populace from the flu, thereby preventing it’s
spread and both the United States Center for Disease Control and
Prevention (CDC) and the World Health Organization (WHO)
recommend yearly vaccination for nearly all people beyond six
months of age, especially if in high risk groups such as pregnant,
healthcare workers, elderly, those with other healthcare conditions
and children between six months and five years of age
References
Vaccines against influenza WHO position paper. Wkly Epidemiol Rec. 2012; 87(47): 461-476.
WHO model list of essential medicines (19th List). World Health Organization Web site. http://www.who.int/medicines/ publications/essentialmedicines/EML_2015_FINAL_amended_ NOV2015.pdf ?ua=1 Published April, 2015. Amended November, 2015. Accessed March 30, 2018.
WHO Should Get Vaccinated Against Influenza. U.S. Centers for Disease Control and Prevention Web site. https://www.cdc. gov/flu/protect/whoshouldvax.htm Published November 4, 2015. Accessed March 30, 2018. e4 Vaccin Res Open J. 2018; 3(1): e4-e5. doi: 10.17140/VROJ-3-e006
Influenza (Seasonal) Fact sheet. World Health Organization. Web site. http://www.who.int/en/news-room/fact-sheets/detail/ influenza-(seasonal). Published November 2016. Accessed March 31, 2018.
Nunnally, Bk, Turula, VE, Sitrin, RD, eds. Vaccine Analysis: Strate-gies, Principles and Control. Heidelberger, Berlin, Germany: Springer. 2014.
Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths Averted by Vaccination in the United States. Centers for Disease Control and Prevention. Web site. https://www.cdc. gov/flu/about/disease/2015-16.htm. Published December 9, 2016. Accessed May 7, 2018.
Key Facts About Seasonal Flu Vaccine. U.S. Centers for Disease Control and Prevention. Web site. https://www.cdc.gov/flu/pro-tect/keyfacts.htm. Accessed March 30, 2018.
Hamilton RJ. Tarascon Pocket Pharmacopoeia 2015. Deluxe Lab-Coat Edition. Burlington, Massachusetts, USA; Jones & Bartlett Learning. 2015.
Stowe J, Andrews N, Wise L, Miller E. Investigation of the tem-poral association of Guillian-Barre Syndrome with influenza vac-cine and influenza like illness using the United Kingdom General Practice Research Database. Am J Epidemiol. 2009; 169(3): 382-388. doi: 10.1093/aje/kwn310 e5 Akinlaja OA
Product Monograph: Flumist, Astrazeneca Canada Inc., 2011. Web site. https://www.astrazeneca.ca/content/dam/az-ca/down-loads/productinformation/flumist-qlaiv-product-monograph-en. pdf. Published. April 19, 2018. Accessed May 7, 2018.
Fell DB, Sprague AE, Liu N, et al. H1N1 influenza vaccina-tion during pregnancy and fetal and neonatal outcomes. Am J Public Health. 2012; 102(6): e33-e40. doi: 10.2105/AJPH.2011.300606.
Inactivated Influenza Vaccine 2007–2008 – What You Need To Know. U.S. Centers for Disease Control and Prevention. Web site. https://web.archive.org/web/20071120001659/http://www.cdc. gov/vaccines/pubs/vis/downloads/vis-flu.pdf. Retrieved March 31, 2018. Accessed May 7, 2018.
Seasonal Flu Shot – Seasonal Influenza (Flu). U.S. Centers for Disease Control and Prevention. Retrieved March 31, 2018.Ac-cessed May 7, 2018.
Pollack A. Rapidly Produced Flu Vaccine Wins F.D.A. Ap-proval. The New York Times. January 16, 2013. https://www. ny-times.com/2013/01/17/business/flublok-a-flu-vaccine-wins-fda-approval.html. Accessed May 7, 2018.
Thiomersal and Vaccines. World Health Organization. Web site. http://www.who.int/vaccine_safety/committee/en/. Pub-lished March 31, 2018. Accessed May 7, 2018.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Vaccination Research (VR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
